IP Library › Assignment 030305/0819
Patent Assignment
Reel/Frame 030305/0819

Assignment of Assignor's Interest

Recorded: 2013-04-29 Pages: 10
Assignor
PARK FUNDING, LLC
Executed: 2012-05-18
Assignee
SIGNALRX PHARMACEUTICALS, INC.
12545 EL CAMINO REAL #C, SAN DIEGO, CALIFORNIA, 92130
Covered Properties (4)
Pi-3 Kinase Inhibitor Prodrugs
Patent: 6,949,537 →
Application: 10/818,145 →
Publication: US 2004/0242631
Pi-3 Kinase Inhibitor Prodrugs
Patent: 7,396,828 →
Application: 11/111,201 →
Publication: US 2005/0203173
Pi-3 Kinase Inhibitor Prodrugs
Patent: 7,662,977 →
Application: 11/962,612 →
Publication: US 2008/0188423
Thienopyranones as Kinase Inhibitors
Patent: 8,557,807 →
Application: 12/735,309 →
Publication: US 2010/0310466
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 13, 2004
From: GARLICH, JOSEPH R.; DURDEN, DONALD L.; PATTERSON, MARY; SU, JINGDONG
To: SEMAFORE PHARMACEUTICALS, INC.
Reel/Frame 014844/0156 →
Security Agreement May 29, 2009
From: SEMAFORE PHARMACEUTICALS, INC.
To: PARK FUNDING, LLC
Reel/Frame 022746/0638 →
Assignment of Assignor's Interest Feb 9, 2010
From: SEMAPHORE PHARMACEUTICALS, INC.
To: PARK FUNDING, LLC
Reel/Frame 023915/0283 →
Corrective Assignment to Correct the Assignor Name Previously Recorded on Reel 023915 Frame 0283. Assignor(S) Hereby Confirms the Correct Assignor Name Is Semafore Pharmaceuticals, Inc.. Aug 17, 2011
From: SEMAFORE PHARMACEUTICALS, INC.
To: PARK FUNDING, LLC
Reel/Frame 026764/0070 →